Red blood cell-derived microparticles (RxMP Therapeutics)

N/A

Report date: 2023/03/06 09:43:46

Base Information

Drug NameRed blood cell-derived microparticles (RxMP Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRxMP Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRxMP Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCerebral Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A